1. Home
  2. CEPU vs RAPP Comparison

CEPU vs RAPP Comparison

Compare CEPU & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Puerto S.A. (each represents ten)

CEPU

Central Puerto S.A. (each represents ten)

HOLD

Current Price

$15.55

Market Cap

1.4B

Sector

Utilities

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$27.93

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CEPU
RAPP
Founded
1989
2022
Country
Argentina
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
CEPU
RAPP
Price
$15.55
$27.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$17.50
$47.00
AVG Volume (30 Days)
350.1K
316.8K
Earning Date
03-10-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$607,552,200.00
N/A
Revenue This Year
$16.07
N/A
Revenue Next Year
$15.36
N/A
P/E Ratio
$12.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.43
$6.43
52 Week High
$18.50
$42.27

Technical Indicators

Market Signals
Indicator
CEPU
RAPP
Relative Strength Index (RSI) 43.91 52.30
Support Level $15.18 $26.57
Resistance Level $16.49 $28.99
Average True Range (ATR) 0.79 1.84
MACD -0.10 0.21
Stochastic Oscillator 15.56 68.69

Price Performance

Historical Comparison
CEPU
RAPP

About CEPU Central Puerto S.A. (each represents ten)

Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: